The Valley Desk

ReviewMolecular therapy. AdvancesPublished

AAV serotype IVDs for patient selection in gene therapy development: Technical and regulatory considerations by ARDAT consortium

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Review
Venue
Molecular therapy. Advances
Published
Subject terms
Patient Selection; In Vitro Diagnostic; Companion Diagnostic; Pre-existing Antibodies; Adeno-associated Virus Gene Therapy; Validation Requirements; Aav Serotype Ivd; Clinically Relevant Cutoff; In Vitro Diagnostic Regulations
PubMed ID
42990908
PubMed Central ID
PMC13734834
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal